RYTM

Rhythm Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↓ 3/10
  • Value↓ 0/10
Rhythm Pharmaceuticals sales and earnings growth
RYTM Growth
Neutral
  • Revenue Y/Y↑ 45.83%
  • EPS Y/Y↑ 28.34%
  • FCF Y/Y↓ -2.41%
Rhythm Pharmaceuticals gross and profit margin trends
RYTM Profitability
Neutral
  • Gross margin ↑ 89.70%
  • EPS margin↓ -106.40%
  • ROIC 5Y↓ -104.13%
Rhythm Pharmaceuticals net debt vs free cash flow
RYTM Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -8.5

Rhythm Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗